Type 2 diabetes mellitus

• Impact of GLP1-RAs on inflammation and endothelial biomarkerS in Type 2 diABetes meLlitus patiEnts: STABLE-GLP1 trial. Pending
  2025-520802-37-00 6
• A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants with Type 2 Diabetes Mellitus(T2DM … Pending
  2025-521401-41-00 3 "Type 2 Diabetes Mellitus (T2DM) and overweight or obesity"
• Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascu … Pending
  2025-522486-29-01 5 "Diabetes Mellitus"
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of CX11 Tablets in Patients with Type 2 Diabetes Mellitus Recruiting
  2025-524514-28-00 4 2026-05-06 "Type 2 Diabetes Mellitus"
• The SEMAFOOT2 Pilot. Effect of semaglutide on healing of foot ulcers in type 2 diabetes patients. A Pilot study. Recruiting
  2023-504913-65-01 4 2026-04-24 "Type 2 diabetes, Diabetic foot ulcer"
• A Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Degludec and Insulin … Recruiting
  2025-522662-67-00 3 2025-08-13 "Type 2 Diabetes Mellitus"
• Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia Trial Recruiting
  2024-511828-14-00 4 2025-05-13 "Type II diabetes melittus (10067585)"
• Effect of Treatment with Finerenone on Cardio-Renal Target Organ Damage in Patients with Type 2 Diabetes – A Randomized Trial Recruiting
  2023-504446-58-00 6 2024-10-15 "Type 2 diabetes, chronic kidney disease"
• Fecal microbiota transfer to improve diabetes control post-bariatric surgery Recruiting
  2024-511870-65-00 5 2024-01-16 "Adults Non Diabete Remission (NDR) Type 2 Diabete (T2D) pati"
• Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY Recruiting
  2022-500143-21-01 6 2023-01-12 "Type 2 diabetes"
• A Phase 1/2 Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM Recruitment ended
  2024-519005-35-00 7 2026-03-09 "Type 2 Diabetes Mellitus"
• Clinical trial to evaluate whether personalized treatment based on genetics improves type 2 diabetes control Recruitment ended
  2025-520686-46-00 6 2025-05-15 "Type 2 Diabetes Mellitus"
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Subjects With Type 2 Diabetes Mell … Recruitment ended
  2024-513539-25-00 4 2024-11-22 "Type 2 Diabetes Mellitus"
• A Double-blind, Placebo-controlled, Multiple-Dose, 2-Period Crossover Study to Evaluate the Effect of Steady-state AZD6793 on the Steady-sta … Halted
  2025-522551-25-00 3 2026-01-14 "Type 2 Diabetes Mellitus"
• Bioequivalence Study of Empagliflozin Ended
  2026-525434-33-00 2 2026-04-07 "Not applicable (submitted trial is a BE study in healthy par"
• The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in the tre … Ended
  2025-522975-27-00 2 2025-09-29 "Not applicable (submitted trial is a BE study in healthy sub"
• The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm … Ended
  2025-522976-10-00 2 2025-09-10 "Not applicable (submitted trial is a BE study in healthy su"
• The bioavailability study of Dapagliflozin Ended
  2025-522234-31-00 2 2025-08-20 "not applicable (submitted trial is a bioequivalence study"
• Investigation of pharmacokinetics, safety and tolerability of a single subcutaneous dose of NNC0487-0111 in participants with various degree … Ended
  2023-509961-19-00 3 2024-07-18 "Obesity and Diabetes mellitus Typ 2"
• A study to evaluate the efficacy and safety of gliclazide MR in patients with type 2 diabetes inadequately controlled with dapagliflozin wit … Ended
  2024-511408-18-00 5 2024-07-15 "Type 2 Diabetes inadequately controlled with dapagliflozin w"
• A study to assess the pharmacokinetics, and glucodynamics of LY3209590 in participants with type 2 diabetes Ended
  2023-508008-39-00 3 2023-12-05 "Type 2 Diabetes Mellitus"
• Exploratory Bioavailability of Two Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed and Fasting Condi … Ended
  2023-507802-15-00 3 2023-11-07
• A Phase I Randomized, Single-center, Double-blind, Two-period Crossover Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and To … Ended
  2024-519646-73-00 3 "Type 2 Diabetes Mellitus"

Showing 1–23 of 23 trials